Comorbidity polypharmacy score and its clinical utility: A pragmatic practitioner′s perspective
Modern medical management of comorbid conditions has resulted in escalating use of multiple medications and the emergence of the twin phenomena of multimorbidity and polypharmacy. Current understanding of how the polypharmacy in conjunction with multimorbidity influences trauma outcomes is limited,...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
| Series: | Journal of Emergencies, Trauma and Shock |
| Subjects: | |
| Online Access: | http://www.onlinejets.org/article.asp?issn=0974-2700;year=2015;volume=8;issue=4;spage=224;epage=231;aulast=Stawicki |
| _version_ | 1818573257633169408 |
|---|---|
| author | Stanislaw P Stawicki Sarathi Kalra Christian Jones Carla F Justiniano Thomas J Papadimos Sagar C Galwankar Scott M Pappada John J Feeney David C Evans |
| author_facet | Stanislaw P Stawicki Sarathi Kalra Christian Jones Carla F Justiniano Thomas J Papadimos Sagar C Galwankar Scott M Pappada John J Feeney David C Evans |
| author_sort | Stanislaw P Stawicki |
| collection | DOAJ |
| description | Modern medical management of comorbid conditions has resulted in escalating use of multiple medications and the emergence of the twin phenomena of multimorbidity and polypharmacy. Current understanding of how the polypharmacy in conjunction with multimorbidity influences trauma outcomes is limited, although it is known that trauma patients are at increased risk for medication-related adverse events. The comorbidity-polypharmacy score (CPS) is a simple clinical tool that quantifies the overall severity of comorbidities using the polypharmacy as a surrogate for the "intensity" of treatment necessary to adequately control chronic medical conditions. Easy to calculate, CPS is derived by counting all known pre-injury comorbid conditions and medications. CPS has been independently associated with mortality, increased risk for complications, lower functional outcomes, readmissions, and longer hospital stays. In addition, CPS may help identify older trauma patients at risk of post-emergency department undertriage. The goal of this article was to review and refine the rationale for CPS and to provide an evidence-based outline of its potential clinical applications. |
| first_indexed | 2024-12-15T00:08:46Z |
| format | Article |
| id | doaj.art-d95f5c2e3dce4788b4ce879c7f56be82 |
| institution | Directory Open Access Journal |
| issn | 0974-2700 |
| language | English |
| last_indexed | 2024-12-15T00:08:46Z |
| publishDate | 2015-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Journal of Emergencies, Trauma and Shock |
| spelling | doaj.art-d95f5c2e3dce4788b4ce879c7f56be822022-12-21T22:42:39ZengWolters Kluwer Medknow PublicationsJournal of Emergencies, Trauma and Shock0974-27002015-01-018422423110.4103/0974-2700.161658Comorbidity polypharmacy score and its clinical utility: A pragmatic practitioner′s perspectiveStanislaw P StawickiSarathi KalraChristian JonesCarla F JustinianoThomas J PapadimosSagar C GalwankarScott M PappadaJohn J FeeneyDavid C EvansModern medical management of comorbid conditions has resulted in escalating use of multiple medications and the emergence of the twin phenomena of multimorbidity and polypharmacy. Current understanding of how the polypharmacy in conjunction with multimorbidity influences trauma outcomes is limited, although it is known that trauma patients are at increased risk for medication-related adverse events. The comorbidity-polypharmacy score (CPS) is a simple clinical tool that quantifies the overall severity of comorbidities using the polypharmacy as a surrogate for the "intensity" of treatment necessary to adequately control chronic medical conditions. Easy to calculate, CPS is derived by counting all known pre-injury comorbid conditions and medications. CPS has been independently associated with mortality, increased risk for complications, lower functional outcomes, readmissions, and longer hospital stays. In addition, CPS may help identify older trauma patients at risk of post-emergency department undertriage. The goal of this article was to review and refine the rationale for CPS and to provide an evidence-based outline of its potential clinical applications.http://www.onlinejets.org/article.asp?issn=0974-2700;year=2015;volume=8;issue=4;spage=224;epage=231;aulast=StawickiComorbidity-polypharmacy scoreelderly trauma patientestimation of frailtymultimorbidityphysiologic agepublic healthworld demographics |
| spellingShingle | Stanislaw P Stawicki Sarathi Kalra Christian Jones Carla F Justiniano Thomas J Papadimos Sagar C Galwankar Scott M Pappada John J Feeney David C Evans Comorbidity polypharmacy score and its clinical utility: A pragmatic practitioner′s perspective Journal of Emergencies, Trauma and Shock Comorbidity-polypharmacy score elderly trauma patient estimation of frailty multimorbidity physiologic age public health world demographics |
| title | Comorbidity polypharmacy score and its clinical utility: A pragmatic practitioner′s perspective |
| title_full | Comorbidity polypharmacy score and its clinical utility: A pragmatic practitioner′s perspective |
| title_fullStr | Comorbidity polypharmacy score and its clinical utility: A pragmatic practitioner′s perspective |
| title_full_unstemmed | Comorbidity polypharmacy score and its clinical utility: A pragmatic practitioner′s perspective |
| title_short | Comorbidity polypharmacy score and its clinical utility: A pragmatic practitioner′s perspective |
| title_sort | comorbidity polypharmacy score and its clinical utility a pragmatic practitioner s perspective |
| topic | Comorbidity-polypharmacy score elderly trauma patient estimation of frailty multimorbidity physiologic age public health world demographics |
| url | http://www.onlinejets.org/article.asp?issn=0974-2700;year=2015;volume=8;issue=4;spage=224;epage=231;aulast=Stawicki |
| work_keys_str_mv | AT stanislawpstawicki comorbiditypolypharmacyscoreanditsclinicalutilityapragmaticpractitionersperspective AT sarathikalra comorbiditypolypharmacyscoreanditsclinicalutilityapragmaticpractitionersperspective AT christianjones comorbiditypolypharmacyscoreanditsclinicalutilityapragmaticpractitionersperspective AT carlafjustiniano comorbiditypolypharmacyscoreanditsclinicalutilityapragmaticpractitionersperspective AT thomasjpapadimos comorbiditypolypharmacyscoreanditsclinicalutilityapragmaticpractitionersperspective AT sagarcgalwankar comorbiditypolypharmacyscoreanditsclinicalutilityapragmaticpractitionersperspective AT scottmpappada comorbiditypolypharmacyscoreanditsclinicalutilityapragmaticpractitionersperspective AT johnjfeeney comorbiditypolypharmacyscoreanditsclinicalutilityapragmaticpractitionersperspective AT davidcevans comorbiditypolypharmacyscoreanditsclinicalutilityapragmaticpractitionersperspective |